Limosilactobacillus reuteri-educated T cells protect against activation of liver inflammation in immunocompromised mice 2229185
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Yuying Liu und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Oral administration of probiotic Limosilactobacillus reuteri DSM 17938 prolongs survival and reduces Th1- and Th2-associated inflammation in Treg-deficient scurfy (SF) mice, which model human IPEX syndrome. It is unclear how DSM 17938 educated SF-CD4+T cells can facilitate T cell-liver communication.
Methods
We adoptively transferred by intraperitoneal injection cells isolated from SF spleens into lymphocyte-deficient-RAG1KO mice and compared the CD4+T cells from SF mice gavage-fed with DSM 17938 with the CD4+T cells from untreated SF mice (Prob-SF-CD4+T cells versus SF-CD4+T cells). Liver inflammatory histology and transcriptomes in RAG1KO mice were analyzed.
Results
We observed that Prob-SF-CD4+T cells reduced the incidence and severity of liver inflammation caused by transferring SF-CD4+T cells. SF-CD4+T cells up-regulated expression of liver genes involved in TLR cascades, inflammatory cytokine and death receptor signals, while down-regulated genes linked to mitochondrial respiratory chain complexes, TCA cycle, liver detoxification and lipid metabolism. However, Prob-SF-CD4+T cell transfer reversed SF-CD4+T cell-induced transcriptomic changes in inflammatory and metabolic clusters by modulating distinct genes participating in TLR regulation, mitochondrial function and cell cycle.
Conclusion
In conclusion, inflammatory CD4+T cells can perpetuate an exaggerated immune response in the immunologically naïve host. DSM17938 has the capacity to reprogram inflammatory CD4+T cells and allowed them to benefit the recipient. Probiotic-modulated T cells can be further explored as a therapeutic option for autoimmune liver diseases. Funding Source National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) R03AI153725 Topic Categories Therapeutic Approaches to Autoimmunity (THER)
Zitieren
APA
Liu, Y., Fadhel-Alvarez, A., Yin, Z., Okeugo, B., Banerjee, A., Giorgberidze, S., Harne, V., Rambabu, M., Yalamanchili, H., Salihi, S. A., & Rhoads, J. M. (2026). Limosilactobacillus reuteri-educated T cells protect against activation of liver inflammation in immunocompromised mice 2229185. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.019
Vancouver
Liu Y, Fadhel-Alvarez A, Yin Z, Okeugo B, Banerjee A, Giorgberidze S, et al. Limosilactobacillus reuteri-educated T cells protect against activation of liver inflammation in immunocompromised mice 2229185. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.019
BibTeX
@article{Liu2026,
author = {Liu, Yuying and Fadhel-Alvarez, Ana and Yin, Zheng and Okeugo, Beanna and Banerjee, Alexander and Giorgberidze, Salomea and Harne, Vaishali and Rambabu, Majji and Yalamanchili, Hari and Salihi, Suhair Al and Rhoads, J Marc},
title = {Limosilactobacillus reuteri-educated T cells protect against activation of liver inflammation in immunocompromised mice 2229185},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.019}
}
EUVIMED